treatment medical

Practice patterns to decrease myopia progression differ among paediatric ophthalmologists around the world
Ari Leshno, Sonal K Farzavandi, Rosario Gomez-de-Liaño, Derek T Sprunger, Tamara Wygnanski-Jaffe, Eedy Mezer

British Journal of Ophthalmology Apr 2020, 104 (4) 535-540; DOI: 10.1136/bjophthalmol-2019-314752
Acanthamoeba keratitis therapy: time to cure and visual outcome analysis for different antiamoebic therapies in 227 cases
Vincenzo Papa, Paolo Rama, Cherry Radford, Darwin C Minassian, John K G Dart

British Journal of Ophthalmology Apr 2020, 104 (4) 575-581; DOI: 10.1136/bjophthalmol-2019-314485
Prevalence of treatment with glaucoma medication in Scotland, 2010–2017
Alan P Rotchford, John Hughes, Pankaj Kumar Agarwal, Andrew J Tatham

British Journal of Ophthalmology Mar 2020, 104 (3) 381-385; DOI: 10.1136/bjophthalmol-2019-314206
Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre
Carol L Shields, Zeynep Bas, Sameeksha Tadepalli, Lauren A Dalvin, Raksha Rao, Rachel Schwendeman, Sara E Lally, Jerry A Shields, Amish Shah, Ann Leahey

British Journal of Ophthalmology Feb 2020, bjophthalmol-2019-315572; DOI: 10.1136/bjophthalmol-2019-315572
Core outcomes for geographic atrophy trials
Aniela Krystyna Krezel, Ruth Hogg, Lynne Lohfeld, Usha Chakravarthy, Augusto Azuara-Blanco

British Journal of Ophthalmology Dec 2019, bjophthalmol-2019-314949; DOI: 10.1136/bjophthalmol-2019-314949
Safety of 6000 intravitreal dexamethasone implants
Bindu Rajesh, Javier Zarranz-Ventura, Adrian T Fung, Catharina Busch, Niroj Kumar Sahoo, Patricio J Rodriguez-Valdes, Valentina Sarao, Sanjay Kumar Mishra, A Osman Saatci, Patricia Udaondo Mirete, Giuseppe Querques, Michel Eid Farah, Paolo Lanzetta, J Fernando Arevalo, Laurent Kodjikian, Jay Chhablani

British Journal of Ophthalmology Jan 2020, 104 (1) 39-46; DOI: 10.1136/bjophthalmol-2019-313991
Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol
Tiezhu Lin, Kunny C Dans, Ilkay Kilic Muftuoglu, Amit Meshi, Manuel J Amador-Patarroyo, Lingyun Cheng, William R Freeman

British Journal of Ophthalmology Jan 2020, 104 (1) 58-63; DOI: 10.1136/bjophthalmol-2018-313447
Changes in neovascular activity following fixed dosing with an anti-vascular endothelial growth factor agent over 52 weeks in the phase III VIEW 1 and VIEW 2 studies
Darius M Moshfeghi, Desmond Thompson, Namrata Saroj

British Journal of Ophthalmology Dec 2019, bjophthalmol-2019-315021; DOI: 10.1136/bjophthalmol-2019-315021
Non-proliferative type II macular telangiectasia variant with subfoveal detachment: role of anti-VEGF therapy
George J Manayath, Ratnesh Ranjan, C K Nagesha, Venkatapathy Narendran

British Journal of Ophthalmology Dec 2019, bjophthalmol-2019-315093; DOI: 10.1136/bjophthalmol-2019-315093
Clinical and microbiological characteristics of Moraxella keratitis
Terence Joseph McSwiney, Susan J Knowles, Conor C Murphy

British Journal of Ophthalmology Dec 2019, 103 (12) 1704-1709; DOI: 10.1136/bjophthalmol-2018-313557

Main menu

treatment medical

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

treatment medical

Pages